Howard B. Schiller

2013

In 2013, Howard B. Schiller earned a total compensation of $4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International, a 41% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,793,123
Salary$1,000,000
Stock Awards$1,166,991
Other$3,872
Total$3,963,988

Schiller received $1.8M in non-equity incentive plan, accounting for 45% of the total pay in 2013.

Schiller also received $1M in salary, $1.2M in stock awards and $3.9K in other compensation.

Rankings

In 2013, Howard B. Schiller's compensation ranked 1,781st out of 12,286 executives tracked by ExecPay. In other words, Schiller earned more than 85.5% of executives.

ClassificationRankingPercentile
All
1,781
out of 12,286
86th
Division
Manufacturing
580
out of 4,614
87th
Major group
Chemicals And Allied Products
155
out of 1,466
89th
Industry group
Drugs
105
out of 1,160
91st
Industry
Pharmaceutical Preparations
91
out of 890
90th
Source: SEC filing on April 29, 2016.

Schiller's colleagues

We found seven more compensation records of executives who worked with Howard B. Schiller at Valeant Pharmaceuticals International in 2013.

2013

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2013

Laizer Kornwasser

Valeant Pharmaceuticals International

Group Chairman

2013

Daniel Wechsler

Valeant Pharmaceuticals International

Group Chairman

2013

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2013

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2013

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2013

Pavel Mirovsky

Valeant Pharmaceuticals International

President and General Manager, Europe

You may also like